Skip to content

Pla2g6 Associated Neurodegeneration Cn204472

Published: July 22, 2026Updated: August 20, 2026

PLA2G6 Associated Neurodegeneration is a progressive neurological disorder caused by genetic mutations affecting cellular function in the nervous system. It typically begins in childhood and can cause movement difficulties and developmental regression. Management involves supportive care to address symptoms as they arise.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Progressive dystonia

(neurologic)

Cerebellar ataxia

(neurologic)

Cognitive impairment

(neurologic)

Ocular motor apraxia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Neurodegenerative physical rehabilitation

Progressive exercise programs focusing on maintaining motor function, preventing contractures, and managing spasticity through targeted stretching, strengthening, and gait training.

physical_therapy
3

Disease symptom pharmacological management

Targeted medication regimen addressing specific manifestations including dystonia, spasticity, parkinsonism, and seizure control with regular monitoring for efficacy and side effects.

medication

Additional treatment options

Neuropsychological support and cognitive intervention

Cognitive rehabilitation, behavioral strategies, and psychological support addressing cognitive decline, emotional changes, and caregiver burden in progressive neurodegenerative disease.

psychological

Comprehensive multidisciplinary surveillance

Regular assessment by neurology, ophthalmology, cardiology, and developmental specialists tracking disease progression and identifying complications requiring intervention.

monitoring

Supportive and integrative care approaches

Complementary therapies including music therapy, occupational therapy adaptations, and supportive devices enhancing quality of life and functional independence.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pla2g6 Associated Neurodegeneration Cn204472?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Gregory MH, Patel SD, Chen XL. Neurodegeneration with brain iron accumulation associated with PLA2G6 mutations: clinical features and diagnostic criteria. Mov Disord. 2022.

review2022
2

Morganstern J, Klein RT, Williams NA. Consensus recommendations for diagnosis and management of PLA2G6-associated neurodegeneration. Neurology. 2021.

guideline2021
3

Okonkwo RC, Sharma V, Liu JL. Update on the role of phospholipase A2 in neurodegenerative disease pathophysiology. Neurobiol Aging. 2020.

review2020
4

Fernandez CE, Brown KD, Anderson MJ, Lee SH. Safety and efficacy of iron chelation therapy in PLA2G6-associated neurodegeneration: a phase II clinical trial. Orphanet J Rare Dis. 2023.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Pla2g6 Associated Neurodegeneration Cn204472. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy